Raymond James Financial Services Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-18,000
| Closed | -$27K | – | 2812 |
|
|
2019
Q3 | $27K | Sell |
18,000
-425
| -2% | -$638 | ﹤0.01% | 2717 |
|
|
2019
Q2 | $74K | Sell |
18,425
-200
| -1% | -$803 | ﹤0.01% | 2706 |
|
|
2019
Q1 | $80K | Buy |
18,625
+25
| +0.1% | +$107 | ﹤0.01% | 2658 |
|
|
2018
Q4 | $107K | Sell |
18,600
-225
| -1% | -$1.29K | ﹤0.01% | 2384 |
|
|
2018
Q3 | $255K | Sell |
18,825
-13,126
| -41% | -$178K | ﹤0.01% | 2375 |
|
|
2018
Q2 | $379K | Buy |
31,951
+13,151
| +70% | +$156K | ﹤0.01% | 2068 |
|
|
2018
Q1 | $211K | Sell |
18,800
-200
| -1% | -$2.25K | ﹤0.01% | 2218 |
|
|
2017
Q4 | $127K | Hold |
19,000
| – | – | ﹤0.01% | 2339 |
|
|
2017
Q3 | $156K | Sell |
19,000
-1,300
| -6% | -$10.7K | ﹤0.01% | 2328 |
|
|
2017
Q2 | $91K | Sell |
20,300
-1,527
| -7% | -$6.85K | ﹤0.01% | 2346 |
|
|
2017
Q1 | $120K | Buy |
+21,827
| New | +$120K | ﹤0.01% | 2231 |
|